Modulation of oligonucleotide CpGmediated immune stimulation by positional modification of nucleosides

Details for Australian Patent Application No. 2005242217 (hide)

Owner Hybridon, Inc.

Inventors Agrawal, Sudhir

Agent Davies Collison Cave

Pub. Number AU-A-2005242217

Parent 783745

Filing date 12 December 2005

Wipo publication date 12 January 2006

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

5 January 2006 Complete Application Filed

12 January 2006 Application Open to Public Inspection

  Published as AU-A-2005242217

2 February 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005242218-Plant growth regulation

2005242216-Motor